Seborrheic keratoses: A study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimod

International Journal of Dermatology

Volumn 43, Issue 4, 2004, Pages 300-302

  Herron, Mark D ^a   Bowen, Anneli R ^a   Krueger, Gerald G ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; DERMATOLOGICAL AGENT; IMIQUIMOD; TAZAROTENE; VANICREAM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREAM; CRYOSURGERY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG FORMULATION; DRUG RESPONSE; ERYTHEMA; FEMALE; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; MALE; OINTMENT; RECURRENT DISEASE; SCAR FORMATION; SEBORRHEIC KERATOSIS; SKIN BURNING SENSATION; SKIN IRRITATION; SKIN ULCER; STANDARD;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AGED; AMINOQUINOLINES; CALCITRIOL; CRYOSURGERY; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; KERATOSIS, SEBORRHEIC; MALE; MIDDLE AGED; NICOTINIC ACIDS; PILOT PROJECTS; RETINOIDS; TREATMENT OUTCOME;

EID: 2342434140     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02282.x     Document Type: Article

References (18)

1. Kee CE. Liquid nitrogen cryotherapy. Arch Dermatol 1967; 96: 198-203.
2. 3) in Seborrheic Keratosis. J Invest Dermatol Symp Proc 1996; 1: 94-96.
3. Berthe-Jones J, Hutchinson PE. Vitamin D analogues and psoriasis. Br J Dermatol 1992; 127: 71-78.
4. Kragballe K. The future of Vitamin D in dermatology. J Am Acad Dermatol 1997; 37: 72-76S.
5. Bikle DD. Vitamin D: A calciotropic hormone regulating calcium-induced keratinocyte differentiation. J Am Acad Dermatol 1997; 37: 42-52S.
6. Coynik D. Evaluating the potential clinical benefits of switching patients with plaque psoriasis from calcipotriene to tazarotene treatment. Cutis 2000; 66: 19-24.
7. Helm TN, Lee J, Helm KF. Spiny keratoderma. Cutis 2000; 66: 191-192.
8. Hengge UR, Esser S, Schultewolter T, et al. Self-administered topical 5 % imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000; 143: 1026-1031.
9. Diaz-Arrastia C, Arany I, Robazetti SC, et al. Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%. Clin Cancer Res 2001; 7: 3031-3033.
10. Smith KJ, Germain M, Skelton H. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluoruracil therapy. Dermatol Surg 2001; 27: 561-564.
11. Marks R, Gebauer K, Shumack S, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001; 44: 807-813.
12. Stockfleth E, Meyer T, Bennighoff B, et al. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol 2001; 144: 1050-1053.
13. Guzzo C, Lazarus G, Goffe BS, et al. Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis. J Am Acad Dermatol 1996; 34: 429-433.
14. Krayenbuhl BH. Allergic and irritant contact dermatitis to calcipotriol. Am J Contact Derm 1999; 10: 78-80.
15. Menter A. Pharmacokinetics and safety of tazarotene. J Am Acad Dermatol 2000; 43: S31-S35.
16. Fitzpatrick RE, Goldman MP, Ruiz-Esparza J. Laser treatment of benign pigmented epidermal lesions using a 300 nsecond pulse and 510 nm wavelength. J Dermatol Surg Oncol 1993; 19: 341-347.
17. 2 laser superpulsed mode. Treatment of verruca vulgaris, seborrheic keratoses, lentigines and actinic cheilitis. J Dermatol Surg Oncol 1994; 20: 449-456.
18. Mehrabi D, Brodell RT. Use of the Alexandrite laser for treatment of seborrheic keratoses. Dermatol Surg 2002; 28: 437-439.